Continuum Clinical’s Pamela Landau Named to PharmaVOICE 100
NORTHBROOK, Ill.--(BUSINESS WIRE)--Oct 30, 2019--
Pamela Landau, senior vice president of integrated solutions at Continuum Clinical, has been recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry.” Landau is the seventh Continuum Clinical executive to be honored in the magazine’s prestigious annual list since its inception in 2005.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191030005702/en/
Pamela Landau, Senior Vice President of Integrated Solutions at Continuum Clinical, was named to the PharmaVOICE “100 Most Inspiring People in the Life-Sciences Industry.” (Photo: Business Wire)
The list, published in the July/August 2019 issue of PharmaVOICE, highlights Landau’s expertise in international business, her inspirational leadership style, and the extensive patient insight experience she has gained from years spent working with some of the largest pharmaceutical and medical device companies in the world.
In her 4 years with Continuum, Landau’s insights have led to the company’s development of a proprietary strategic patient recruitment framework and to the creation of the Integrated Solutions group which she leads. The Integrated Solutions group encompasses multiple teams and functions, including patient insights research, patient advocacy and diversity and inclusion, creative, digital and traditional media. Together, the group executes the patient-centric process of developing and implementing strategies that effectively reach and motivate the target patient, leading to complete trial enrollment.
Landau’s fluency in Japanese and her expertise in global healthcare systems has made her an indispensable asset to the company. She is credited with deepening Continuum’s global patient recruitment reach and has contributed to the success in multiple large-scale global patient recruitment programs.
“Pamela is an important reason we are able to have a such a distinguished presence in Asia-Pacific,” said Neil Weisman, President of Continuum Clinical. “Her extensive expertise and unique skillset enables Continuum to succeed with our global partners and as a result, 70% of our patient recruitment campaigns are run globally. Her passion and leadership empowers the entire company to function as one integrated team, and we are all proud that she was named to the PharmaVoice 100.”
The PharmaVOICE 100 list honors influential leaders from a broad cross section of the global life-sciences industry, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, advertising, digital, marketing, technology, academia, and many other sectors. Landau’s PharmaVoice distinction follows Continuum Clinical being named a Medical Marketing & Media’s Top 100 Agency for 2019 this July.
About Continuum Clinical
Continuum Clinical is a global clinical trial enrollment company, providing fact-based patient recruitment solutions that deliver results. With over twenty-five years of experience, Continuum Clinical provides sponsors and CROs with patient recruitment and retention planning, study and site support, patient recruitment campaigns, patient advocacy and diversity & inclusion services, retention solutions, and reporting and analytics. We specialize in identifying and solving challenges that can impact successful clinical trial enrollment, from protocol development through study completion. Headquartered in the US, Continuum Clinical has more than 140 employees in the US and Europe and an expanded network of resources worldwide.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191030005702/en/
CONTACT: Cate Layne
CLayne@continuumclinical.com
Senior Manager, Corporate Brand & Content
847-664-5143
KEYWORD: ILLINOIS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS
SOURCE: Continuum Clinical
Copyright Business Wire 2019.
PUB: 10/30/2019 11:24 AM/DISC: 10/30/2019 11:24 AM
http://www.businesswire.com/news/home/20191030005702/en